Last Posted: May 18, 2017
Variations in Duchenne muscular dystrophy course in a multi-ethnic UK population: potential influence of socio-economic factors.
Hufton Margaret et al. Developmental medicine and child neurology 2017 May
Newborn screening for Duchenne muscular dystrophy in China: Follow-up diagnosis and subsequent treatment.
Ke Qing et al. World journal of pediatrics : WJP 2017 May
FDA approves drug to treat Duchenne muscular dystrophy
Reuters Health, February 9, 2017
Researchers find genetic cause of new type of muscular dystrophy
Medical Xpress, February 9, 2017
DMDtoolkit: a tool for visualizing the mutated dystrophin protein and predicting the clinical severity in DMD.
Zhou Jiapeng et al. BMC bioinformatics 2017 Feb 18(1) 87
Using Administrative Data to Ascertain True Cases of Muscular Dystrophy: Rare Disease Surveillance.
Smith Michael G et al. JMIR public health and surveillance 2017 Jan 3(1) e2
Disclaimer: Articles listed in the Public Health Knowledge Base are selected by the CDC Office of Public Health Genomics to provide current awareness of the literature and news. Inclusion in the update does not necessarily represent the views of the Centers for Disease Control and Prevention nor does it imply endorsement of the article's methods or findings. CDC and DHHS assume no responsibility for the factual accuracy of the items presented. The selection, omission, or content of items does not imply any endorsement or other position taken by CDC or DHHS. Opinion, findings and conclusions expressed by the original authors of items included in the update, or persons quoted therein, are strictly their own and are in no way meant to represent the opinion or views of CDC or DHHS. References to publications, news sources, and non-CDC Websites are provided solely for informational purposes and do not imply endorsement by CDC or DHHS.